| |
| |
|
| Insider
Information: |
Seizinger Bernd R. |
| Relationship: |
|
| City: |
Boston |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
50,685 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$20,740 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
50,685 |
|
|
| Total
Value |
$20,740 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Aprea Therapeutics, Inc. |
APRE |
Director |
2024-03-13 |
33,685 |
2019-10-07 |
0 |
Premium* |
|
|
Aptose Biosciences Inc |
APTO |
|
2023-09-22 |
17,000 |
2023-09-22 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
9 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| APRE |
Aprea Therapeutics, Inc. |
Director |
– • – |
2024-03-13 |
4 |
B |
$7.29 |
$50,009 |
D/D |
6,860 |
33,685 |
2.39 |
- |
|
| APTO |
Aptose Biosciences Inc |
|
• • – |
2023-09-22 |
4 |
B |
$3.14 |
$53,380 |
D/D |
17,000 |
17,000 |
0.01 |
% |
|
| APRE |
Aprea Therapeutics, Inc. |
Director |
– • – |
2023-08-23 |
4 |
A |
$0.00 |
$0 |
D/D |
500 |
26,825 |
0 |
- |
|
| APRE |
Aprea Therapeutics, Inc. |
Director |
– • – |
2023-06-07 |
4 |
B |
$3.68 |
$22,192 |
D/D |
6,029 |
26,325 |
2.39 |
- |
|
| APRE |
Aprea Therapeutics, Inc. |
Director |
– • – |
2023-06-06 |
4 |
B |
$3.63 |
$14,764 |
D/D |
4,068 |
20,296 |
2.39 |
- |
|
| APRE |
Aprea Therapeutics, Inc. |
Director |
– • – |
2022-07-28 |
4 |
A |
$0.00 |
$0 |
D/D |
5,995 |
324,575 |
0 |
- |
|
| APRE |
Aprea Therapeutics, Inc. |
Director |
– • – |
2022-05-18 |
4 |
B |
$0.71 |
$35,500 |
D/D |
50,000 |
318,580 |
2.39 |
- |
|
| APRE |
Aprea Therapeutics, Inc. |
Director |
– • – |
2021-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
4,610 |
268,580 |
0 |
- |
|
| APRE |
Aprea Therapeutics, Inc. |
|
• • – |
2019-10-07 |
4 |
OE |
$0.07 |
$18,478 |
D/D |
263,970 |
263,970 |
0 |
- |
|
9 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
